Genedata Profiler 15.0 リリース：
Genmab社と連携しデータ活用時の利便性を大幅に強化

Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the release of Genedata Profiler^® 15.0, the latest version of its enterprise software that makes translational and clinical research data more accessible, enabling scientists to make data-informed decisions through all stages of biopharma development. The latest release adds a highly intuitive portal that enables researchers and clinical scientists to find, access, and integrate the most relevant data for their specific application in a secure, high-performance, validation-ready environment.

Genedata Profiler 15.0 is the result of a development project in close collaboration between Genedata and Genmab, an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

“We have the brightest data scientists in the industry working on advancing our products through all stages of development with the goal of bringing effective therapies to patients as quickly as possible,” said Hisham Hamadeh, Ph.D., Vice President, Global Head of Data Sciences at Genmab. “The Genedata Profiler platform is used productively in a validated environment and is helping to democratize access to integrated data in the translational research and clinical settings.”

New features in Genedata Profiler include a new Data Portal with an interactive interface for secure self-service data access across all available studies and experiments, automated Data Ingestion Workflows with a wizard-like interface to load, structure, and quality-control data, and the improvement of interoperability with third-party tools to ingest, process, quality-control, and analyze data programmatically.

“We are excited about the success of our partnership with Genmab, a pioneer in the field of innovative biopharmaceuticals,” said Othmar Pfannes, Ph.D., CEO of Genedata. “The latest release of Genedata Profiler addresses key requirements of innovative biopharmaceutical R&D organizations. As the single source of truth for all translational and clinical research data, Genedata Profiler fuels innovation—a big step in biopharma digitalization. We look forward to expanding the Genedata Profiler platform over the next few years with our partners, to enable them to bring innovative biotherapeutics to the market even faster.”